{
  "id": "c4f77f515254f28e254d66d05a4be09e833c8f4e",
  "title": "Keep EU drug price agreements confidential or risk market disruption [Advocacy Lab]",
  "summary_full": "US benchmarking of drug prices against foreign markets could have unintended consequences, says Czech health economist Tomáš Doležal, he urges EU to protect pricing confidentiality",
  "summary_public": "US benchmarking of drug prices against foreign markets could have unintended consequences, says Czech health economist Tomáš Doležal, he urges EU to protect pricing confidentiality",
  "url": "https://www.euractiv.com/news/keep-eu-drug-price-agreements-confidential-or-risk-market-disruption/",
  "published_at": "2026-02-26T23:05:06+00:00",
  "source": "Euractiv",
  "language": "en",
  "countries_detected": [
    "CZ"
  ],
  "countries_scored": [
    "CZ"
  ],
  "sentiment_error": "No batch result returned for this item",
  "llm_version": null,
  "llm_perspective": null,
  "llm_attempted_at": "2026-02-28T09:41:01+00:00"
}